Capital Fund Management (CFM)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.43M | Buy |
19,200
+7,900
| +70% | +$2.93M | 0.03% | 725 |
|
|
2026
Q1 | $3.31M | Sell |
11,300
-43,100
| -79% | -$14.2M | 0.02% | 1111 |
|
|
2025
Q4 | $19.1M | Sell |
54,400
-21,300
| -28% | -$7.2M | 0.05% | 511 |
|
|
2025
Q3 | $24.5M | Buy |
+75,700
| New | +$23.5M | 0.06% | 429 |
|
|
2021
Q3 | – | Sell |
-17,100
| Closed | -$6.53M | – | 1597 |
|
|
2021
Q2 | $6.53M | Buy |
+17,100
| New | +$6.53M | 0.05% | 470 |
|
|
2020
Q2 | – | Sell |
-1,400
| Closed | -$318K | – | 1178 |
|
|
2020
Q1 | $318K | Sell |
1,400
-14,100
| -91% | -$3.84M | ﹤0.01% | 1201 |
|
|
2019
Q4 | $4.68M | Buy |
15,500
+7,300
| +89% | +$2.01M | 0.04% | 559 |
|
|
2019
Q3 | $1.97M | Sell |
8,200
-29,200
| -78% | -$8M | 0.02% | 797 |
|
|
2019
Q2 | $10.6M | Buy |
37,400
+1,000
| +3% | +$273K | 0.1% | 289 |
|
|
2019
Q1 | $10.4M | Sell |
36,400
-17,300
| -32% | -$5M | 0.09% | 290 |
|
|
2018
Q4 | $14.1M | Sell |
53,700
-7,200
| -12% | -$1.98M | 0.12% | 218 |
|
|
2018
Q3 | $16.7M | Buy |
60,900
+5,200
| +9% | +$1.35M | 0.09% | 332 |
|
|
2018
Q2 | $13.3M | Buy |
55,700
+4,000
| +8% | +$926K | 0.07% | 388 |
|
|
2018
Q1 | $11.4M | Buy |
51,700
+31,500
| +156% | +$7.4M | 0.07% | 403 |
|
|
2017
Q4 | $4.54M | Buy |
20,200
+6,900
| +52% | +$1.47M | 0.03% | 705 |
|
|
2017
Q3 | $2.52M | Sell |
13,300
-4,000
| -23% | -$761K | 0.02% | 713 |
|
|
2017
Q2 | $3.25M | Sell |
17,300
-10,000
| -37% | -$1.8M | 0.03% | 608 |
|
|
2017
Q1 | $4.51M | Buy |
27,300
+15,300
| +128% | +$2.43M | 0.04% | 512 |
|
|
2016
Q4 | $1.73M | Buy |
12,000
+3,100
| +35% | +$415K | 0.01% | 819 |
|
|
2016
Q3 | $1.11M | Buy |
+8,900
| New | +$1.15M | 0.01% | 927 |
|
|
2016
Q1 | – | Sell |
-25,000
| Closed | -$3.49M | – | 1604 |
|
|
2015
Q4 | $3.49M | Buy |
25,000
+13,300
| +114% | +$1.83M | 0.04% | 532 |
|
|
2015
Q3 | $1.64M | Sell |
11,700
-20,100
| -63% | -$3.02M | 0.02% | 675 |
|
|
2015
Q2 | $5.22M | Buy |
31,800
+22,400
| +238% | +$3.58M | 0.07% | 379 |
|
|
2015
Q1 | $1.45M | Sell |
9,400
-47,200
| -83% | -$6.72M | 0.02% | 665 |
|
|
2014
Q4 | $7.11M | Sell |
56,600
-11,000
| -16% | -$1.36M | 0.08% | 325 |
|
|
2014
Q3 | $8.09M | Buy |
67,600
+46,200
| +216% | +$5.3M | 0.09% | 277 |
|
|
2014
Q2 | $2.3M | Buy |
21,400
+7,100
| +50% | +$732K | 0.02% | 676 |
|
|
2014
Q1 | $1.42M | Sell |
14,300
-10,300
| -42% | -$932K | 0.02% | 815 |
|
|
2013
Q4 | $2.27M | Buy |
24,600
+14,500
| +144% | +$1.29M | 0.03% | 654 |
|
|
2013
Q3 | $844K | Buy |
10,100
+2,900
| +40% | +$249K | 0.01% | 940 |
|
|
2013
Q2 | $589K | Buy |
+7,200
| New | +$539K | 0.01% | 954 |
|
Other funds holding ELV
Capital Fund Management (CFM)'s ELV Position: Q2 2026 in Review
Capital Fund Management (CFM) sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 52,982 shares — an estimated $19.6M sold.
Capital Fund Management (CFM) first reported a position in ELV in Q4 2013 and held it in 35 quarters. The position peaked at $33M in Q2 2023. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Capital Fund Management (CFM) reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Capital Fund Management (CFM) sold 52,982 Elevance Health shares in Q2 2026, an estimated $19.6M.
- Capital Fund Management (CFM) first reported a position in Elevance Health in Q4 2013 and held it in 35 quarters.
- Capital Fund Management (CFM)'s Elevance Health position peaked at $33M in Q2 2023.
- 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.